This paper contains new, representative reference equations for the viscosity of n-hexane. The equations are based in part upon a body of experimental data that has been critically assessed for internal consistency and for agreement with theory whenever possible. The correlations are valid from the triple point to 600 K, and at pressures up to 100 MPa. We estimate the expanded uncertainty at a 95% confidence level to be 2% for the liquid phase at temperatures from the triple point to 450 K and pressures to 100 MPa. For the liquid at 450–600 K at pressures to 100 MPa, the expanded uncertainty at the 95% confidence level is 6%, and is 0.3% for the low-density gas at pressures to 0.3 MPa.

No abstract

This paper contains a new wide-ranging correlation for the viscosity of n-heptane based on critically evaluated experimental data. The correlation is valid from the triple point (182.55 K) to 600 K, and at pressures up to 248 MPa. The estimated uncertainty at a 95% confidence level is 3.5% over the whole range (with the exception of the near-critical region). Along the saturated liquid curve, the estimated uncertainty is 1% below 292 K, 0.6% in the region from 292 to 346 K, rising to 2% between 346 and 363 K, and 0.3% for the low-density gas at temperatures from 317 to 600 K and pressures to 0.3 MPa.

No abstract

Complement dysregulation has been documented in adults with COVID-19 and implicated in relevant pediatric inflammatory responses against SARS-CoV-2. We propose that signatures of complement missense coding SNPs associated with dysregulation could also be identified in children with multisystem inflammatory syndrome (MIS-C). We investigated 71 pediatric patients with RT-PCR validated SARS-CoV-2 hospitalized in pediatric COVID-19 care units (November 2020–March 2021) in three major groups. Seven (7) patients suffered from MIS-C (MIS-C group), 32 suffered from COVID-19 and were hospitalized (admitted group), whereas 32 suffered from COVID-19, but were sent home. All patients survived and were genotyped for variations in the C3, C5, CFB, CFD, CFH, CFHR1, CFI, CD46, CD55, MASP1, MASP2, MBL2, COLEC11, FCN1, and FCN3 genes. Upon evaluation of the missense coding SNP distribution patterns along the three study groups, we noticed similarities, but also considerably increased frequencies of the alternative pathway (AP) associated with SNPs rs12614 CFB, rs1061170, and rs1065489 CFH in the MIS-C patients. Our analysis suggests that the corresponding substitutions potentially reduce the C3b-inactivation efficiency and promote slower and weaker AP C3bBb pre-convertase assembly on virions. Under these circumstances, the complement AP opsonization capacity may be impaired, leading to compromised immune clearance and systemic inflammation in the MIS-C syndrome.